<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on July 28, 2020</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT04429074</url>
  </required_header>
  <id_info>
    <org_study_id>RECHMPL20_0348</org_study_id>
    <nct_id>NCT04429074</nct_id>
  </id_info>
  <brief_title>Registrar Performances in MIDP</brief_title>
  <official_title>Registrar Performance in Laparoscopic Distal Pancreatectomy and Its Effect on Postoperative Outcomes</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>University Hospital, Montpellier</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>University Hospital, Montpellier</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      This study aimed to determine whether registrar involvement in minimally invasive distal
      pancreatectomy (MIDP) was associated with adverse outcomes.
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      From January 2009 to March 2020, data of all consecutive patients requiring distal
      pancreatectomy in our public tertiary hospital were prospectively collected and
      retrospectively analyzed.

      Registrars were progressively involved for MIDP since 2009 and their experience was: &lt; 5 open
      pancreatic resections, &lt; 5 MIDP and at least 30 advanced minimally invasive gastrointestinal
      resections.

      Outcome of patients who underwent either distal pancreatectomy by the consultant or
      registrars were compared.

      Our primary outcome was the conversion rate. The secondary outcomes were 90-days
      postoperative outcomes including CR-POPF defined and classified according to the 2016 ISGPF
      definition.
    </textblock>
  </detailed_description>
  <overall_status>Completed</overall_status>
  <start_date type="Actual">December 1, 2019</start_date>
  <completion_date type="Actual">June 1, 2020</completion_date>
  <primary_completion_date type="Actual">December 30, 2019</primary_completion_date>
  <study_type>Observational</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <observational_model>Case-Control</observational_model>
    <time_perspective>Retrospective</time_perspective>
  </study_design_info>
  <primary_outcome>
    <measure>open conversion rate</measure>
    <time_frame>1 day</time_frame>
    <description>Necessity to swith from minimally invasive approach to open approach during laparoscopy</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Duration of surgery</measure>
    <time_frame>1 day</time_frame>
    <description>Duration of surgery</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Intraoperative bloodloss</measure>
    <time_frame>1 day</time_frame>
    <description>Intraoperative bloodloss</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Intraoperative transfusion</measure>
    <time_frame>1 day</time_frame>
    <description>Intraoperative transfusion</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>severe complications Clavien Dindo&gt;3</measure>
    <time_frame>90 days postoperative</time_frame>
    <description>severe complications Clavien Dindo&gt;3</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>postoperative complications</measure>
    <time_frame>90 days postoperative</time_frame>
    <description>postoperative complications</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>clinically relevant postoperative fistula</measure>
    <time_frame>90 days postoperative</time_frame>
    <description>clinically relevant postoperative fistula (2016 ISGPF definition)</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>lenght of hospital stay</measure>
    <time_frame>90 days postoperative</time_frame>
    <description>lenght of hospital stay</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>readmission rate</measure>
    <time_frame>90 days postoperative</time_frame>
    <description>readmission rate</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>reoperation rate</measure>
    <time_frame>90 days postoperative</time_frame>
    <description>reoperation rate</description>
  </secondary_outcome>
  <number_of_groups>2</number_of_groups>
  <enrollment type="Actual">71</enrollment>
  <condition>Minimally Invasive Distal Pancreatectomy</condition>
  <arm_group>
    <arm_group_label>Group 1 (Registrar)</arm_group_label>
    <description>Group 1 (Registrar): Patients who underwent minimally invasive distale pancreatectomy for benign or borderline pathology operated on by a registrar (young specialist surgeon)</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Group 2 (Consultant)</arm_group_label>
    <description>Group 2 (Consultant): Patients who underwent minimally invasive distale pancreatectomy for benign or borderline pathology operated on by a consultant (expert)</description>
  </arm_group>
  <intervention>
    <intervention_type>Procedure</intervention_type>
    <intervention_name>Minimally invasive distal pancreatectomy</intervention_name>
    <description>Minimally invasive distal pancreatectomy</description>
    <arm_group_label>Group 1 (Registrar)</arm_group_label>
    <arm_group_label>Group 2 (Consultant)</arm_group_label>
  </intervention>
  <eligibility>
    <study_pop>
      <textblock>
        Patients who underwent minimally invasive distale pancreatectomy for benign or borderline
        pathology
      </textblock>
    </study_pop>
    <sampling_method>Non-Probability Sample</sampling_method>
    <criteria>
      <textblock>
        Inclusion criteria:

        - Patients who underwent minimally invasive distale pancreatectomy for benign or borderline
        pathology between 2009-2020

        Exclusion criteria:

          -  open distal pancreatectomy

          -  minimally invasive distal pancreatectomy for pancreatic cancer

          -  20 first consecutive patients operated on by the consultant (learning curve)
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>99 Years</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>REGIS SOUCHE</last_name>
    <role>Study Director</role>
    <affiliation>University Hospital, Montpellier</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>Uhmontpellier</name>
      <address>
        <city>Montpellier</city>
        <zip>34295</zip>
        <country>France</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>France</country>
  </location_countries>
  <verification_date>June 2020</verification_date>
  <study_first_submitted>June 9, 2020</study_first_submitted>
  <study_first_submitted_qc>June 9, 2020</study_first_submitted_qc>
  <study_first_posted type="Actual">June 12, 2020</study_first_posted>
  <last_update_submitted>June 9, 2020</last_update_submitted>
  <last_update_submitted_qc>June 9, 2020</last_update_submitted_qc>
  <last_update_posted type="Actual">June 12, 2020</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <keyword>Benign or borderline pathology (non-pancreatic cancer)</keyword>
  <keyword>laparoscopy</keyword>
  <keyword>registrar</keyword>
  <keyword>postoperative outcomes</keyword>
  <keyword>pancreatectomy</keyword>
  <keyword>surgery</keyword>
  <keyword>pancreas</keyword>
  <patient_data>
    <sharing_ipd>Undecided</sharing_ipd>
    <ipd_description>NC</ipd_description>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

